Watchlist Price Alert

Lineage Cell Therapeutics... (LCTX)

AMEX: LCTX · Real-Time Price · USD

0.68

0.02 (2.30%)

At close: Jun 02, 2025, 1:06 PM

2.30% (1D)

Bid	0.67
Market Cap	154.14M
Revenue (ttm)	9.56M
Net Income (ttm)	-16.21M
EPS (ttm)	-0.07
PE Ratio (ttm)	-9.64
Forward PE	-13.77
Analyst	Buy

Ask	0.68
Volume	525,707
Avg. Volume (20D)	1,360,312
Open	0.68
Previous Close	0.66
Day's Range	0.65 - 0.68
52-Week Range	0.37 - 1.15
Beta	1.42

About LCTX

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol LCTX

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for LCTX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

6 months ago

-28.99%

Lineage Cell Therapeutics shares are trading lower... Unlock content with Pro Subscription

9 months ago

+1.8%

Lineage Cell Therapeutics shares are trading higher after the company reported better-than-expected Q2 financial results.

News

2 weeks ago · businesswire.com

Lineage to Present at 3rd Annual H.C. Wainwright BioConnect Investor Conference at Nasdaq NYC

CARLSBAD, Calif.--(BUSINESS WIRE)---- $LCTX #LineageCellTherapeutics--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell ...

2 weeks ago · zacks.com

Lineage Cell (LCTX) Reports Q1 Loss, Lags Revenue Estimates

Lineage Cell (LCTX) came out with a quarterly loss of $0.02 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.04 per share a year ago.

2 weeks ago · seekingalpha.com

Lineage Cell Therapeutics, Inc. (LCTX) Q1 2025 Earnings Call Transcript

Lineage Cell Therapeutics, Inc. (NYSE:LCTX ) Q1 2025 - Earnings Conference Call May 13, 2025 4:30 PM ET Company Participants Ioana Hone - Head of Investor Relations Brian Culley - Chief Executive Offi...

Lineage Cell Therapeutics, Inc. (NYSE:LCTX ) Q4 2024 Earnings Conference Call March 10, 2025 4:30 PM ET Company Participants Ioana Hone - Head of Investor Relations Brian Culley - Chief Executive Offi...